www.venock.com Open in urlscan Pro
2001:1520:a:32::  Public Scan

Form analysis
0 forms found in the DOM

Text Content

 * Home
 * Medical Need
 * Venock Solution
 * About us
 * News
 * Contact
 * Impressum

close


VASCULAR CLOSURE SYSTEM FOR LARGE BORE ACCESS

The Venock vascular closure device will address a tremendously growing medical
need and will have a significant positive impact on the clinical practice of
interventional cardiologists.

LEARN MORE
Video Player
00:00
00:00
02:00
Use Up/Down Arrow keys to increase or decrease volume.







prevnext
 * prev
 * Venock Box
 * next

navigation




 * Home
 * Medical Need
 * Venock Solution
 * About us
 * News
 * Contact
 * Impressum




MEDICAL NEED


THERAPEUTIC PROCEDURES THAT REQUIRE
LARGE BORE VENOUS ACCESS CLOSURE


CURRENT TRANS-VENOUS PROCEDURES

Current therapies that require large bore venous vascular access:

 

 * ASD Closure
 * Left Arterial Appendix Occluder
 * Mitral Valve Repair (currently only one technology available)
 * Vena Cava Filter
 * Atrial Ablation
 * Pulmonary Embolectomy
 * Venous Thrombectomy
    

These trans-venous therapies add up to approximately 5 million procedures per
year in USA and Europe.


UPCOMING TRANS-VENOUS PROCEDURES

A dramatic increase in interventional procedures that require large bore venous
vascular access site is expected once novel technologies under development for
structural heart treatment in development will mature.

 * Transcatheter Mitral Valve Repair
 * Transcatheter Mitral Valve Prosthesis Implantation
 * Transcatheter Tricuspid Valve Repair
 * Transcatheter Tricuspid Valve Prosthesis Implantation
 * Intra-Atrial Shunt Therapy
 * Left Ventricle Restoration
 * Left Ventricle Volume Reduction
 * Right Ventricle Assist Devices

As soon as these procedures are fully developed and utilized, the market for
large bore venous access closure is expected to grow to 30 million procedures
per year in the USA and Europe.


AS OF TODAY THERE EXISTS NO EFFECTIVE VASCULAR CLOSURE DEVICE FOR LARGE BORE
PUNCTURES OF VENOUS VESSELS IN THE CLINICAL PRACTICE.


SOLUTION


THE VENOCK SYSTEM


THE VENOCK VASCULAR CLOSURE DEVICE IS A PERCUTANEOUS HAND HELD DEVICE FOR
AUTOMATED CLOSURE OF A LARGE BORE PUNCTURE IN THE FEMORAL VEIN FOLLOWING AN
INTERVENTIONAL PROCEDURE. THE DEVICE IS INSERTED OVER THE ALREADY POSITIONED
GUIDEWIRE IN THE VEIN AND THE PERFORATION IS TIGHTLY SEALED WITHIN 1-2 MINUTES
PROCEDURE TIME.


ADVANTAGES OF VENOCK VASCULAR CLOSURE DEVICE


CLOSURE WITHIN 1-2 MINUTES

The current practice is to stop venous bleeding with half an hour manual
pressure, followed by compression bandage and 6 hours immobilization.

Quick sealing of the vein puncture will allows for earlier patient mobilization.


EARLIER DISCHARGE

The current practice is to keep patients overnight in the hospital, being
immobilized and bedridden with a compression bandage and sand sack.

Quick sealing of the vein puncture will allow for earlier patient discharge.


LESS COMPLICATIONS

Sealing of the vein puncture by compression results in hematoma, pain and
swelling. Patient immobilization increases the risk for vein thrombosis.

Reliable and quick sealing of vein puncture will reduce serious complications.


COST SAVINGS

Quick sealing of the vein puncture will free up resources and more
interventional procedures can be converted from inpatient to outpatient
settings.

Consequently, the utilization of Venock Closure device is cost effective.


ADVANTAGE FOR


HOSPITALS AND MEDTECH DEVICE DEVELOPERS


ABSTRACT OF THE WHITE PAPER

The Venock device offers benefits for many different stakeholders. In addition
to improving patient comfort, the Venock device aids in the general acceptance
of large bore transcatheter interventions, which benefits device developers and,
of course, hospitals and clinics.

The Venock device allows for more efficient cathlab capacity utilization and
higher patient turnover, while drastically reducing cost and recovery time.
Cathlabs are determined to find ways to save resources and increase patient
turnover in order to make transcatheter procedures more profitable.

Although cathlab resources are limited, it is in the chief interest of global
MedTech companies to streamline cathlab procedures in order to increase the
number of procedures per day. The Venock vascular closure device is such a
device that will drastically reduce patient length of stay and use of resources,
while allowing for higher patient turnover, faster mobilization, and earlier
discharge.

DOWNLOAD THE FULL DOCUMENT (248.7 KiB)






DR. SAMEER GAFOOR

> Large-bore femoral venous access is becoming more commonplace, but access
> closure still often requires hours of postprocedural monitoring and bedrest.
> 
> I am happy to hear that Venock is developing a large bore venous closure that
> facilitate early hospital discharge for this fast-growing patient population.
> 
>  

CARDIOLOGIST
STRUCTURAL HEART DISEASE SWEDISH MEDICAL CENTER, SEATTLE, WA, USA


CARLOS E. RUIZ, MD, PHD, FACC, FESC, MSCAI

> I think extended external groin compression in patients undergoing
> cardiovascular interventions is by far, one of the most common dreadful
> memories that patients have afterwards. We have done major steps in avoiding
> this when we do arterial access using a multitude of closing devices. The
> problem is now more prominent with the increasing use of large-bore venous
> access for a multitude of new procedures. The Venock device will be the next
> step solution to improve further patient satisfaction
> 
>  

CARDIOLOGIST
FORMER DIRECTOR STRUCTURAL HEART, LENOX HILL HEART AND VASCULAR INSTITUTE, NEW
YORK, USA


PROF. DR. HORST SIEVERT

> Arterial closure devices have tremendously improved the post-interventional
> recovery process by saving time and resources, decreasing patient discomfort,
> and eliminating complications like hematoma. I am looking forward to seeing
> the same benefits in large bore venous closure.
> 
> The Venock device will attain large bore venous closure in under a minute,
> thus saving time and money, while significantly reducing patient discomfort
> and time to discharge when compared to the recovery from manual compression.

CARDIOLOGIST, INTENSIVIST
DIRECTOR OF CENTER FOR CARDIOLOGY, PERIPHERAL VASCULAR AND CEREBROVASCULAR
DISEASE FRANKFURT, GERMANY




prev

next

 * prev
 * 1
 * 2
 * 3
 * 4
 * next


OUR MANAGEMENT TEAM


POWERED BY PEOPLE

 * E-Mail
 * LinkedIn


TERRY BARNES

CHIEF EXECUTIVE OFFICER

Learn more

 * E-Mail
 * LinkedIn


DIPL.-KFM. MARCUS IRSFELD

CHIEF FINANCIAL OFFICER

Learn more

 * E-Mail
 * LinkedIn


DR. WOLFGANG GOETZ

FOUNDER & CHAIRMAN OF THE BOARD

Learn more


OUR ACHIEVEMENTS


NEWS


SAFETY/EFFICACY OF ITS AUTOMATED CLOSURE DEVICE

2021-07-21: Venock Reports Safety/Efficacy of Its Automated Closure Device for
Large Bore Venous Access Sites as Alternative to Standard Manual Compression of
Veins/Arteries in Interventional Procedures

Read more … Safety/Efficacy of Its Automated Closure Device


EXPENSION OF THE CLOSURE DEVICE

2020-07-23: Venock Inc. Paves the Way for First Universal Large Bore Vascular
Closure System Designed for Veins and Arteries

Read more … Expension of the Closure Device


FIRST CLOSING OF SEED INVESTMENT ROUND

2019-03-01: Newly founded and privately held U.S. medical technology company
Venock, Inc. announces first closing of seed financing.

Read more … First closing of Seed Investment Round


CONTACT


GET IN TOUCH


HEAD QUARTER USA

VENOCK INC.

521 Fifth Avenue, Floor 17 | New York, NY 10175 | USA




OPERATIONS GERMANY

VENOCK MEDICAL GMBH

c/o WeWork | Neuturmstrasse 5 | 80331 München | Germany




MEETING US AT EVENTS

We plan to attend the following events and are looking forward to arranging a
meeting with you.

 

Currently there are no events.


ARE YOU INTERESTED IN AN INVESTMENT OR IN A JOINT DEVELOPMENT?
PLEASE CONTACT US.


WIPANO PATENTFÖRDERUNG

Förderprogramm WIPANO des Bundesministeriums für Wirtschaft und Energie

External link: http://www.wipano.de



Nach oben
Skip navigation
 * Venock Inc / Venock Medical GmbH

 

Imprint | Privacy Policy | © Copyright 2023 Venock Medical GmbH

We use cookies to give you the best possible experience on our website. By
continuing to browse this site, you give consent for cookies to be used. For
more details please read our privacy policy. Privacy Policy
Opt-out from Google Analytics
ACCEPT